Cargando…
Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis
BACKGROUND: This research aims to assess the response to acid suppression therapy in gastroesophageal reflux disease (GERD)-related chronic laryngitis (CL). METHODS: Data were extracted from Web of Knowledge, Embase, and PubMed for English language article published up to March 2016. Pooled overall...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059042/ https://www.ncbi.nlm.nih.gov/pubmed/27749540 http://dx.doi.org/10.1097/MD.0000000000004868 |
_version_ | 1782459364578164736 |
---|---|
author | Yang, Yue Wu, Haitao Zhou, Jian |
author_facet | Yang, Yue Wu, Haitao Zhou, Jian |
author_sort | Yang, Yue |
collection | PubMed |
description | BACKGROUND: This research aims to assess the response to acid suppression therapy in gastroesophageal reflux disease (GERD)-related chronic laryngitis (CL). METHODS: Data were extracted from Web of Knowledge, Embase, and PubMed for English language article published up to March 2016. Pooled overall response rate (ORR) rates were evaluated to determine acid suppression treatment efficacy. Random effects model was used with standard approaches to sensitivity analysis, quality assessment, heterogeneity, and exploration of publication bias. RESULTS: Pooled data from 21 reports (N = 2864, antireflux medicine: 2741; antireflux surgery: 123, study duration 4–108 week) were analyzed. With the random-effect model, the ORR was 66% (95% confidence interval [CI] 54%–78%). The ORRs were 80% for antireflux surgery (95% CI 67%–93%, 3 studies, 123 patients), whereas 64% for antireflux medicine (95% CI 50%–77%, 18 studies, 2741 patients), and the ORR was 70% (95% CI 55%–85%, 15 reports, 2731 patients) for >8 weeks’ therapy duration, whereas 57% (95% CI 48%–65%, 6 reports, 133 patients) for ≤8 weeks’ duration of therapy. CONCLUSIONS: Acid suppression seems to be an effective therapy for GERD-related CL. There was an increase in effect among patients with surgery therapeutic method and longer therapy duration. |
format | Online Article Text |
id | pubmed-5059042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-50590422016-11-01 Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis Yang, Yue Wu, Haitao Zhou, Jian Medicine (Baltimore) 4500 BACKGROUND: This research aims to assess the response to acid suppression therapy in gastroesophageal reflux disease (GERD)-related chronic laryngitis (CL). METHODS: Data were extracted from Web of Knowledge, Embase, and PubMed for English language article published up to March 2016. Pooled overall response rate (ORR) rates were evaluated to determine acid suppression treatment efficacy. Random effects model was used with standard approaches to sensitivity analysis, quality assessment, heterogeneity, and exploration of publication bias. RESULTS: Pooled data from 21 reports (N = 2864, antireflux medicine: 2741; antireflux surgery: 123, study duration 4–108 week) were analyzed. With the random-effect model, the ORR was 66% (95% confidence interval [CI] 54%–78%). The ORRs were 80% for antireflux surgery (95% CI 67%–93%, 3 studies, 123 patients), whereas 64% for antireflux medicine (95% CI 50%–77%, 18 studies, 2741 patients), and the ORR was 70% (95% CI 55%–85%, 15 reports, 2731 patients) for >8 weeks’ therapy duration, whereas 57% (95% CI 48%–65%, 6 reports, 133 patients) for ≤8 weeks’ duration of therapy. CONCLUSIONS: Acid suppression seems to be an effective therapy for GERD-related CL. There was an increase in effect among patients with surgery therapeutic method and longer therapy duration. Wolters Kluwer Health 2016-10-07 /pmc/articles/PMC5059042/ /pubmed/27749540 http://dx.doi.org/10.1097/MD.0000000000004868 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 4500 Yang, Yue Wu, Haitao Zhou, Jian Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis |
title | Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis |
title_full | Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis |
title_fullStr | Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis |
title_full_unstemmed | Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis |
title_short | Efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis |
title_sort | efficacy of acid suppression therapy in gastroesophageal reflux disease-related chronic laryngitis |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059042/ https://www.ncbi.nlm.nih.gov/pubmed/27749540 http://dx.doi.org/10.1097/MD.0000000000004868 |
work_keys_str_mv | AT yangyue efficacyofacidsuppressiontherapyingastroesophagealrefluxdiseaserelatedchroniclaryngitis AT wuhaitao efficacyofacidsuppressiontherapyingastroesophagealrefluxdiseaserelatedchroniclaryngitis AT zhoujian efficacyofacidsuppressiontherapyingastroesophagealrefluxdiseaserelatedchroniclaryngitis |